A highly motivated young professional who is passionate about research, development and innovation (R&D&I). My goal is to grow professionally in the area of cancer immunotherapy. After graduated in Biotechnology in 2014, I pursued an MSc in Translational Medical Research at one of the top 50 universities in the world, Ruprecht-Karl University of Heidelberg, with a specialization in Translational Oncology. Once I finished my master’s thesis in targeted cancer therapy at the German Cancer Research Center (DKFZ), I moved to the Netherlands and became a Development Scientist at Glycostem Therapeutics, a biotechnology company developing Natural Killer cell-based immunotherapies for cancer. After working for 2.5 years in cellular immunotherapy I decided to take my career a step further and in September 2020, I started my PhD in Cancer Immunotherapy at IdiSNA, Navarra Institute for Health Research and University of Navarra.
A highly motivated young professional who is passionate about research, development and innovation (R&D&I). My goal is to grow professionally in the area of cancer immunotherapy. After graduated in Biotechnology in 2014, I pursued an MSc in Translational Medical Research at one of the top 50 universities in the world, Ruprecht-Karl University of Heidelberg, with a specialization in Translational Oncology. Once I finished my master’s thesis in targeted cancer therapy at the German Cancer Research Center (DKFZ), I moved to the Netherlands and became a Development Scientist at Glycostem Therapeutics, a biotechnology company developing Natural Killer cell-based immunotherapies for cancer. After working for 2.5 years in cellular immunotherapy I decided to take my career a step further and in September 2020, I started my PhD in Cancer Immunotherapy at IdiSNA, Navarra Institute for Health Research and University of Navarra.